Skip to main content
OpenTrials
Completed

NCT Number: NCT03316430

Podocyturia as Predictive Factor for Pre-eclampsia

Pre-eclampsia is an hypertensive disorder appearing during pregnancy, inducing serious maternal, fetal and neonatal mortality and morbidity. Podocyn could be identified in the urine, before proteinuria, a key element in the diagnostic of pre-eclampsia. Preventive treatment using aspirin could be administrated in early pregnancy. We hypothesized that podocyturia could be an early indicator of preeclampsia. This is a prospective, non-interventional, monocentric study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pre-eclampsia Female Urogenital Diseases and Pregnancy Complications Hypertension, Pregnancy-Induced Pregnancy Complications Urogenital Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Department of obstetrics, Femme Mère Enfant Hospital, Lyon, France

Bron, 69677, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women aged 18 years or more
  • single pregnancy
  • first planned prenatal visit before 16 weeks of gestation
  • planned delivery at Hôpital Femme Mère Enfant in Lyon, France
  • patient receiving information and non opposition to participate

Exclusion criteria

  • multiple pregnancy
  • pregnancy stopped
  • antecedent of nephropathy
  • inability to understand information provided
  • prisoner or under administrative supervision
  • fetal malformation, chromosomal anomalies
  • preterm delivery for other reason that any hypertensive disorder of pregnancy or Intrauterine growth restriction

Treatment and study plan

Podocyturia quantification

Other

Podocyturia quantification at first planned prenatal care visit before 16 weeks of gestation

Primary outcomes

  1. Occurrence of pre-eclampsia

    Time frame: At childbirth (around 8 months)

    Occurrence of pre-eclampsia during pregnancy

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Prospective Study : Podocyturia as Predictive Factor for Pre-eclampsia

Acronym: PEPOD1

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Oct 20, 2017
Registry last updated
Jan 12, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.